Bjorn Sjostrand

Bjorn Sjostrand serves as CEO at Scandinavian Biopharma. Scandinavian Biopharma operates in the pharmaceuticals sector with approximately 44.0 employees. The company is headquartered in Stockholm, Stockholm County.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 2,710 executive contacts are available in Stockholm County.
• • Our database includes 201,469 c suite-level executives.

Outlook Google Maps (Non Paid Users) WordPress.org Nginx Google Tag Manager Mobile Friendly Google Maps Google Font API Typekit

pharmaceutical manufacturing biopharma vaccine development clinical trials etec vaccine immunoglobulins diarrhoea travellers diarrhoea global health children's health biotech vaccine manufacturing vaccine registration biopharmaceutical products healthcare solutions public health disease prevention immunogenicity safety profile research & development medical need low-income countries vaccine commercialization oral vaccine clinical efficacy vaccine candidate pathogen etec infection immunization strategy toxin neutralization phase iib trial vaccine infrastructure public-private partnerships vaccination policy disease burden vaccine distribution market access research partnerships government collaboration horizon 2020 edctp path organization bill & melinda gates foundation vaccination programs health interventions childhood diseases traveller health vaccine formulation pharmaceuticals medical health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Bjorn Sjostrand in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Scandinavian Biopharma.

Bjorn Sjostrand's Position in the MessageCEO Database

• •Bjorn Sjostrand is 1 of 1 verified executive contact we track at Scandinavian Biopharma.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •2,690 verified executive contacts in Stockholm County are in the database.
• •8 verified contacts work at pharmaceuticals companies in the 44.0 employee range (same size as Scandinavian Biopharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Bjorn Sjostrand directly?

Bjorn Sjostrand's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Scandinavian Biopharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Bjorn Sjostrand work for?

Bjorn Sjostrand is CEO at Scandinavian Biopharma, a company in the pharmaceuticals sector with 44.0 employees. The company is based in Stockholm, Stockholm County.

Can I pitch or sell to Bjorn Sjostrand?

As CEO at Scandinavian Biopharma, Bjorn Sjostrand is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Bjorn Sjostrand directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Bjorn Sjostrand in?

Bjorn Sjostrand works in the pharmaceuticals industry as CEO at Scandinavian Biopharma. MessageCEO provides verified contact information for executives across all major industries.

Is Bjorn Sjostrand's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Bjorn Sjostrand's profile is kept up-to-date with the latest available information.

Last updated: July 23, 2026